摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-1-<4-(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene | 89946-05-4

中文名称
——
中文别名
——
英文名称
(Z)-1-<4-(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene
英文别名
cis-3,4',5-tri(benzyloxy)stilbene;(Z)-1-(4-(benzyloxy)phenyl)-2-(3,5-bis(benzyloxy)phenyl) ethene;(Z)-1-(4-(benzyloxy)phenyl)-2-(3,5-bis(benzyloxy)phenyl)ethene;(Z)-1-[4-(benzyloxy)phenyl]-2-(3,5-bis(benzyloxy)phenyl)ethene;1,3-bis(phenylmethoxy)-5-[(Z)-2-(4-phenylmethoxyphenyl)ethenyl]benzene
(Z)-1-<4-(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene化学式
CAS
89946-05-4
化学式
C35H30O3
mdl
——
分子量
498.621
InChiKey
DNTQLVRXOUFTAQ-MSUUIHNZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    678.9±50.0 °C(Predicted)
  • 密度:
    1.168±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    8.6
  • 重原子数:
    38
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    27.7
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:bf6d200e1bc3ab69f409f58db3c8ab72
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (Z)-1-<4-(benzyloxy)phenyl>-2-<3,5-bis(benzyloxy)phenyl>ethene 作用下, 以 氯仿 为溶剂, 反应 12.0h, 以100%的产率得到白藜芦醇三苄醚
    参考文献:
    名称:
    Method for the conversion of a Z-isomer into E-isomer
    摘要:
    一种将通式(II)中的(Z)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯的方法,其中R1、R2和R3相同或不同,且独立地代表(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷氧基(C1-C4)烷基,烯丙基,乙烯基,硅基,甲酰基,酰基,芳基(C1-C4)烷基或取代芳基(C1-C4)烷基基团。本发明还提供了一种将通过上述方法制备的通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(III)中的E-白藜芦醇的方法。
    公开号:
    US20040015020A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogs of piceatannol
    摘要:
    A series of hydroxylated trans-stilbenes related to the antileukemic natural product trans-3,3',4,5'-tetrahydroxystilbene (piceatannol) (1) has been prepared and tested for inhibition of the lymphoid cell lineage-specific protein-tyrosine kinase p56lck, which plays an important role in lymphocyte proliferation and immune function. A number of the analogues displayed enhanced enzyme inhibitory activity relative to the natural product. Reduction of the double bond bridging the two aromatic rings and benzylation of the phenolic hydroxyl groups was found to decrease activity significantly. The most potent compounds in the series proved to be trans-3,3',5,5'-tetrahydroxystilbene, trans-3,3',5-trihydroxystilbene, and trans-3,4,4'-trihydroxystilbene.
    DOI:
    10.1021/jm00072a015
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of Resveratrol and Analogues as Apoptosis-Inducing Agents
    作者:Marinella Roberti、Daniela Pizzirani、Daniele Simoni、Riccardo Rondanin、Riccardo Baruchello、Caterina Bonora、Filippo Buscemi、Stefania Grimaudo、Manlio Tolomeo
    DOI:10.1021/jm030785u
    日期:2003.7.1
    Resveratrol 1 (3,4',5-trihydroxy-trans-stilbene), a phytoalexin present in grapes and other food products, has recently been suggested as a potential cancer chemopreventive agent based on its striking inhibitory effects on cellular events associated with cancer initiation, promotion, and progression. This triphenolic stilbene has also displayed in vitro growth inhibition in a number of human cancer cell lines. In this context, a series of cis- and trans-stilbene-based resveratrols were prepared with the aim of discovering new lead compounds with clinical potential. All the synthesized compounds were tested in vitro for cell growth inhibition and the ability to induce apoptosis in HL60 promyelocytic leukemia cells. The tested trans-stilbene derivatives were less potent than their corresponding cis isomers, except for trans-resveratrol, whose cis isomer was less active. The best results were obtained with compounds 11b and 7b, the cis-3,5-dimethoxy derivatives of rhapontigenin 10a (3,5,3'-trihydroxy-4'methoxy-trans-stilbene) and its 3'-amino derivative 10b, respectively, which showed apoptotic activity at nanomolar concentrations. The corresponding trans isomers 12b and 8b were less active both as antiproliferative and as apoptosis-inducing agents. Of interest, 11b and 7b were active toward resistant HL60R cells and their activity was higher than that of several classic chemotherapeutic agents. The flow cytometry assay showed that at 50 nM compounds 7b or 11b were able to recruit almost all cells in the apoptotic sub-G(0)-G(1) peek, thus suggesting that the main mechanism of cytotoxicity of these compounds could be the activation of apoptosis. These data indicate unambiguously that structural alteration of the stilbene motif of resveratrol can be extremely effective in producing potent apoptosis-inducing agents.
  • US6844471B2
    申请人:——
    公开号:US6844471B2
    公开(公告)日:2005-01-18
  • [EN] METHOD FOR THE CONVERSION OF A Z-ISOMER INTO E-ISOMER<br/>[FR] MÉTHODE DE CONVERSION D'UN ISOMÈRE Z EN UN ISOMÈRE E
    申请人:ORCHID CHEMICALS & PHARM LTD
    公开号:WO2004009539A2
    公开(公告)日:2004-01-29
    A method of converting (Z)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (II) to (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I). wherein R1, R2, R3 are same or different and independently represent (C1-C4)alkyl, (C1-C4)alkoxy(C1-C4)alkyl, (C1-C4)alkoxy(C1-C4)alkoxy(C1-C4)alkyl, allyl, vinyl, silyl, formyl, acyl, aryl(C1-C4)alkyl or substituted aryl(C1-C4)alkyl group and also provides a method for subsequent conversion of (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I) prepared by a process described above to E-resveratrol of the formula (III).
  • Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogs of piceatannol
    作者:Kshitij Thakkar、Robert L. Geahlen、Mark Cushman
    DOI:10.1021/jm00072a015
    日期:1993.10
    A series of hydroxylated trans-stilbenes related to the antileukemic natural product trans-3,3',4,5'-tetrahydroxystilbene (piceatannol) (1) has been prepared and tested for inhibition of the lymphoid cell lineage-specific protein-tyrosine kinase p56lck, which plays an important role in lymphocyte proliferation and immune function. A number of the analogues displayed enhanced enzyme inhibitory activity relative to the natural product. Reduction of the double bond bridging the two aromatic rings and benzylation of the phenolic hydroxyl groups was found to decrease activity significantly. The most potent compounds in the series proved to be trans-3,3',5,5'-tetrahydroxystilbene, trans-3,3',5-trihydroxystilbene, and trans-3,4,4'-trihydroxystilbene.
  • Method for the conversion of a Z-isomer into E-isomer
    申请人:ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED
    公开号:US20040015020A1
    公开(公告)日:2004-01-22
    A method of converting (Z)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (II) to (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I) 1 wherein R 1 , R 2 and R 3 are same or different and independently represent (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy(C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy(C 1 -C 4 )alkoxy(C 1 -C 4 )alkyl, allyl, vinyl, silyl, formyl, acyl, aryl(C 1 -C 4 )alkyl or substituted aryl(C 1 -C 4 )alkyl group. The present invention also provides a process for the conversion of (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I) prepared by a process described above to E-resveratrol of the formula (III). 2
    一种将通式(II)中的(Z)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯的方法,其中R1、R2和R3相同或不同,且独立地代表(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷氧基(C1-C4)烷基,烯丙基,乙烯基,硅基,甲酰基,酰基,芳基(C1-C4)烷基或取代芳基(C1-C4)烷基基团。本发明还提供了一种将通过上述方法制备的通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(III)中的E-白藜芦醇的方法。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸